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BACKGROUND 
• Computational modeling and simulation (M&S) 
methods have substantial potential to support 
research, clinical decision and education in 
healthcare 
 
• Government agencies and industry are making 
substantial investments on R&D activities in 
simulation-based medicine and notable 
discoveries are being made 
 
• Common practice guidelines do not exist to 








& Multiscale Modeling (MSM) Consortium 
To bridge this gap, the 
Committee on Credible Practice of  
Modeling & Simulation in Healthcare 
was established under 
DEFINITION OF SIMULATION 
Credible Practice of Modeling & Simulation in Healthcare 
computational solution of models to quantify 
descriptive and predictive metrics of system(s) of 
interest; including related post-processing efforts 
to calculate these metrics from raw analysis results 
CHARGE: OVERVIEW 
CHARGE: IMPLEMENTATION STRATEGY 
None of us are experts in everything. 
We need to learn from each other. 
Credible practice of modeling and simulation in healthcare 
requires ongoing inclusive communications to establish 
adaptive workflows that can be utilized broadly. 
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COMMUNICATION           ACCOUNTABILITY 
CHARGE: IMPLEMENTATION STRATEGY 
The Committee is divided into 
three Task Teams that represent 
the fundamental areas that are 
significant to our primary aims. 
 
This team-based structure helps 
to: 
 
• Establish a balanced 
representation of the interests 
and perspectives of the 
different stakeholders 
 
• Bridge synergistic activities in 
simulation-based medicine 
throughout the M&S 
communities 
GOAL: ESTABLISH CREDIBLE PRACTICE GUIDELINES 
The Committee’s primary deliverable by the end of the first two year 
term (03/2015) is to establish, “Guidelines for Credible Practice of 
Modeling and Simulation in Healthcare” 
 
Goal Oriented Activity: The CPMS Task Teams were charged to 
identify ten key elements or simple rules of credible practice in order 
to establish a foundation from which the “Guidelines for Credible 
Practice of Modeling and Simulation in Healthcare” can be 
developed. 
 
Full details of this activity is available at: 
http://wiki.simtk.org/cpms/Ten_Simple_Rules_of_Credible_Practice  
ONGOING: TEN SIMPLE RULES OF CREDIBLE PRACTICE 
• Use version control 
• Use credible solvers 
• Explicitly list your limitations 
• Define the context the model is intended to 
be used for 
• Define your evaluation metrics in advance 
• Use appropriate data (input, validation, 
verification) 
• Attempt validation within context 
• Attempt verification within context 
• Attempt uncertainty (error) estimation 
• Perform appropriate level of sensitivity 
analysis within context of use 
• Disseminate whenever possible (source 
code, test suite, data, etc) 
• Report appropriately 
• Use consistent terminology or define your 
terminology  
• Get it reviewed by independent 
users/developers/members 
• Learn from discipline-independent examples 
• Be a discipline-independent/specific example 
• Follow discipline-specific guidelines 
• Conform to discipline-specific standards 
• Document your code 
• Develop with the end user in mind 
• Provide user instructions whenever possible 
and applicable 
• Practice what you preach 
• Make sure your results are reproducible 
• Provide examples of use 
• Use traceable data that can be traced back 
to the origin 
• Use competition of multiple implementations 
to check and balance each other 
To initiate the Ten Simple Rules task, the following 26 simple rule candidates 
were initially generated and surveyed internally by the Committee. 
ONGOING: INTERNAL SURVEY RESULTS ANALYSIS 
#  Consolidated & Rephrased Rules 
1  
Plan and develop the M&S with clear definition of the intended purpose or context, and with 
end-user input  
2  
Document the your code and the M&S (domain of validity/invalidity, intended use, user guide, 
etc), and make your code readable  
3  Use version control  
4  Test the M&S Appropriately within Context (V&V, UQ, sensitivity analysis (SA), test cases)  
5  Use appropriate data  
6  Disseminate whenever and whatever possible  
7  Explicitly list the limitations of the M&S  
8  Adopt and promote standard operating procedures  
9  Use competition of multiple implementations to check and balance each other  
10  Make it easy for anyone to reproduce and/or falsify your results  
11  Use traceable data that can be traced back to the origin  
12  Define your evaluation metrics in advance  
13  Have the M&S reviewed by independent users/developers/members  
Full details are available at: 
http://wiki.simtk.org/cpms/Ten_Simple_Rules_of_Credible_Practice/Summary_of_Results  
These results will be analyzed and reported in more detail in an upcoming 
presentation at the 2014 ASME V&V Symposium in May. 
UPCOMING: COMMUNITY AND MODEL SURVEYS 
Simulation-Based Healthcare Community Survey: To ensure that we 
capture the perspectives and interests of the global stakeholder 
community, we are preparing to launch a public survey of the new 
33 simple rule candidates (increase due to internal survey results) 
 
Survey of Models: To complement the survey,  we are also 
conducting a survey of computational models to develop a better 
understanding of the needs and successes of different types and 
applications of M&S in healthcare 
 
How can the SSH Community Participate? 
• We strongly encourage the SSH community to participate in 
and promote the survey 
• Contribute M&S examples that may help us better 
understand the needs and successes of different types and 
application of M&S within the SSH community 
 
  
UPCOMING: TEN SIMPLE RULES, GUIDELINES & CERT. 
“GUIDELINES FOR 
CREDIBLE PRACTICE 
OF M&S IN 
HEALTHCARE” 














• Determining FFRCT for clinical decision-
making purposes in terms of coronary 
artery disease 
 
• Suitable for teaching purposes centered 
around FFR (and FFRCT) 
 
• Computing FFRCT for diagnosing of other 
parts of the vasculature 
 
• Utilizing quantities from the simulation 
other than FFRCT (e.g., pressure, wall 
shear stress) for clinical decisions 
Used clinical studies specifically designed  
to evaluate the efficacy of the model for 
non-invasive cardiac diagnostic relative to 
the traditional invasive FFR 
 
• HeartFlow NXT Study (2013) – 254 patients 
• DeFACTO Study (2012) – 252 patients 
• DISCOVER-FLOW Study (2011) – 103 
patients 
Intended use: Computes Fractional Flow 
Reserve (FFR) from non-invasive computed 
tomography images. 
 
Limitations:  Clinical studies assess only the 
accuracy of the FFRCT quantity for coronary 
arteries 
EXAMPLE: FRACTIONAL FLOW RESERVE - CT 
Description Credibility Assessment 
Inappropriate Application Appropriate Application 
Provide supporting evidence for: 
• Bone fracture risk due to spaceflight 
related bone loss in terrestrial and 
spaceflight environment  
• Injury criteria definition: additional for 
fitness of duty evaluations for spaceflight, 
and injury loading thresholds 
• Changes to inflight injury likelihood 
resulting from exercise or pharmaceutical 
countermeasures to bone loss  
• As a sole source of evidence to make 
decisions regarding bone fracture risk – 
credibility level is not sufficient for this 
 
• Predict changes in  bone volumetric 
density or architectural changes – µQCT 




Compared to two published data sets that 
are considered to be among the latest state 
of knowledge in bone loss and risk of 
fracture 
  
• Development and Validation of a 
Predictive Bone Fracture Risk Model for 
Astronauts, Annals of Biomedical 
Engineering, 2009, Vol. 37, Number 11, 
2337-2359 
Intended use: Probabilistic risk assessment of 
bone fracture due to bone changes due to 
zero-gravity exposure – analyses may be run 
for spaceflight or terrestrial scenarios 
 
Limitations: 
• Small n - “Attributable” data for model 
development 
• Uses DXA BMD, which has a limited 
correlation to bone strength or [ 
resistance to fracture], and bone quality 
 
EXAMPLE: BONE FRACTURE RISK MODEL 
Description Credibility Assessment 
Inappropriate Application Appropriate Application 
• A teaching tool to provide very high level 
insight of how the cardiovascular system 
may respond to various stressors and 
interventions built into the simulation 
environment 
• The educator should emphasize the 
simulations should be used as a 
supplement and not a replacement of 
their core curriculum 
• Conducting simulation scenarios that 
violate the primary assumptions 
• Simulations of other physiologic systems 
• Attempting to use the model for research 
or clinical purposes; credibility 
assessment is not sufficient for these kinds 
of applications, and it was developed for 
teaching purposes 
• Verification against simple test cases 
• Face/qualitative validation against 
literature data by physicians and 
physiologists for general trends in 
physiologic responses 
• Numerical stability and sensitivity analysis 
were not performed 
• Historical development data and versions 
were not documented 
Intended use: Education model to teach 
medical students about the general 
response of the cardiovascular system to 
various physiologic stresses, and 
administration of various interventions 
 
Limitations: Assumes average adult male 
between the ages of 25 and 55, weighing 
180 lbs, and 5’ 9” tall 
EXAMPLE: GROSS CARDIOVASCULAR PHYSIOLOGY 
Description Credibility Assessment 
Inappropriate Application Appropriate Application 
Note: This is a generalized example based off of a real use case of an educational model 
GOAL: A COMMON LANGUAGE ACROSS DISCIPLINES 
Goal Oriented Activity: A glossary of terms is being generated on 
the Committee’s to help unify the use of M&S vocabulary across a 
variety of disciplines and stakeholders in the field 
 
We strongly encourages all stakeholders (e.g. SSH community) to 
help establish these terms and definitions by visiting: 
http://wiki.simtk.org/cpms/Glossary_and_Definitions  
Example 
GOAL: ADOPTION OF GUIDELINES BY STAKEHOLDERS 
Goal Oriented Activity: We are taking every opportunity to engage 
and strongly encourage the global stakeholder community, such as 
the Society for SSH, to actively contribute to these efforts to ensure 
that the guidelines established capture the primary interests of the 
computational medicine community 
URL: https://simtk.org/home/cpms   Open discussions and 
contribution to activities 
via: 
• Wiki pages 
• Discussion forum 
• Meeting minutes 
• Subversion repository 
access of all 
presentations, 
abstracts and posters 
 
FUTURE WORK 
• Launch public survey to the global community 
(~3 months) – Projected launch date: ??/2014 
 
• Analyze data, and publish results in PLOS 
Computational Biology in the form of “Ten Simple 
Rules of Credible Practice of M&S in Healthcare” 
– Estimated submission date: ??/2014 
 
• Develop and publish the “Guidelines for Credible 
Practice in Modeling & Simulation in Healthcare” 
based off of the Ten Simple Rules – Estimated 
completion date: 03/2015  
OPEN FLOOR DISCUSSION 
• What are the areas that are most important to you in 
simulation-based healthcare? 
 
• Have we’ve missed something? 
 
• What are the challenges you face in applying 
simulations effectively to educate the healthcare 
practitioners? 
 
• Are there any use cases you want to discuss with us?   
Please take advantage of the survey, public forum and wiki site to 
continue this conversation with us. The guidelines will ultimately 
belong to you, so we want to hear from you! 
Committee on Credible Practice of  




Credible Practice of Modeling & Simulation in Healthcare 
dependable with a desired certainty level to 
guide research or support decision making within 
a prescribed application domain and intended 
use; establishing reproducibility & accountability 
DEFINITIONS 
Credible Practice of Modeling & Simulation in Healthcare 
any activity involving development, solution, 
interpretation and application of computational 
representation of biological, environmental and 
man-made systems and their interaction thereof 
DEFINITIONS 
Credible Practice of Modeling & Simulation in Healthcare 
specifically computational modeling; virtual 
representation of system(s) of interest in a usable 
form in order to provide descriptive and 
predictive metrics for timely and systematic 
exploration of the system(s) 
DEFINITIONS 
Credible Practice of Modeling & Simulation in Healthcare 
any activity involving development, maintenance, 
advancement, or administration of medical care; 
including research, diagnosis, risk assessment, 
prevention, therapy, rehabilitation, surgery, 
intervention design, and regulation 
Modeling for Coronary Artery 
Disease Diagnostics 
• Fractional Flow 
Reserve (FFR) 




– Invasive procedure 
• Heartflow’s FFRCT 
technology 
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Video from http://heartflow.com 





construct geometric model 
of main vessels of interest 
discretize model  into 
mesh for computation 
model conditions at inlets and outlets 
of geometric model 
computational fluid 
dynamics used to 
compute velocities and 
pressures, from which 
FFRCT can then be 
derived 
Taylor, CA, Fonte, TA, Min, JK, “Computational Fluid Dynamics Applied to Cardiac Computed Tomography for Noninvasive Quantification of Fractional 
Flow Reserve,” 2013, JACC, 61(22):2233-2241 
BUILDING CONFIDENCE IN THE MODEL 
• Started out with simple, 
“easy-to-test” in vitro model 
over 10 years ago 
• Methods developed and tested to 
address limitations in the interim 
• Assessing what model can be 
used for 
– Original idea:  prediction of surgical 
bypass surgeries 
– Recent clinical studies assess 
technology for coronary artery flow, 
not necessarily applicable to other 
parts of the vasculature  
(to add:  graph of results from one clinical study) 
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BONE FRACTURE RISK MODEL 
• What can we do to estimate astronaut risk of 
fracture? 
• Real and Present Concern: Skeletal Fracture 
– Weakened bones 
– Unique and off-nominal loading states 
• Lack of In Flight Injuries 
– Predictive data is limited 
• Fracture risk 
– Likelihood (unknown)+ Severity (known) 
• Our Question is: 
– What is the fracture likelihood in space (ISS, 
Orion) and on planetary activities (Moon and 
Mars)? 
– Can such assessments be extended to the BMD 
recovery period after return? 








THE LOADING ENVIRONMENT 
“Drop Landing” 
Lateral/Posterolateral 






      Ascent/Decent 
Micro-g Translation 
MODEL VALIDATION AND PREDICTIVE RESULTS  
• Although femoral neck fracture 
is of high concern 
– Least likely location of fracture 




 EMU properties 
Conforms to NASA-STD-7009 
Nelson et al.,  
Development and Validation of a 
 Predictive Bone Fracture Risk 
Model for Astronauts, 
Annals of Biomedical Engineering, 
 Vol 37, Number 11, 2337-2359 
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